These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 25046270)
41. Equid herpesvirus 1 (EHV1) infection of equine mesenchymal stem cells induces a pUL56-dependent downregulation of select cell surface markers. Claessen C; Favoreel H; Ma G; Osterrieder N; De Schauwer C; Piepers S; Van de Walle GR Vet Microbiol; 2015 Mar; 176(1-2):32-9. PubMed ID: 25582614 [TBL] [Abstract][Full Text] [Related]
42. Role of gB and pUS3 in Equine Herpesvirus 1 Transfer between Peripheral Blood Mononuclear Cells and Endothelial Cells: a Dynamic In Vitro Model. Spiesschaert B; Goldenbogen B; Taferner S; Schade M; Mahmoud M; Klipp E; Osterrieder N; Azab W J Virol; 2015 Dec; 89(23):11899-908. PubMed ID: 26378176 [TBL] [Abstract][Full Text] [Related]
43. Abortigenic but Not Neurotropic Equine Herpes Virus 1 Modulates the Interferon Antiviral Defense. Poelaert KCK; Van Cleemput J; Laval K; Favoreel HW; Soboll Hussey G; Maes RK; Nauwynck HJ Front Cell Infect Microbiol; 2018; 8():312. PubMed ID: 30258819 [TBL] [Abstract][Full Text] [Related]
44. Prevalence of equine herpesvirus-1 and equine herpesvirus-4 infections in equidae species in Turkey as determined by ELISA and multiplex nested PCR. Ataseven VS; Dağalp SB; Güzel M; Başaran Z; Tan MT; Geraghty B Res Vet Sci; 2009 Apr; 86(2):339-44. PubMed ID: 18649902 [TBL] [Abstract][Full Text] [Related]
45. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination. Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075 [TBL] [Abstract][Full Text] [Related]
46. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals. Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474 [TBL] [Abstract][Full Text] [Related]
47. Equine herpesvirus 1 glycoprotein D expressed in E. coli provides partial protection against equine herpesvirus infection in mice and elicits virus-neutralizing antibodies in the horse. Weerasinghe CU; Learmonth GS; Gilkerson JR; Foote CE; Wellington JE; Whalley JM Vet Immunol Immunopathol; 2006 May; 111(1-2):59-66. PubMed ID: 16473414 [TBL] [Abstract][Full Text] [Related]
49. Herpesviruses in respiratory liquids of horses: putative implication in airway inflammation and association with cytological features. Fortier G; van Erck E; Fortier C; Richard E; Pottier D; Pronost S; Miszczak F; Thiry E; Lekeux P Vet Microbiol; 2009 Oct; 139(1-2):34-41. PubMed ID: 19427139 [TBL] [Abstract][Full Text] [Related]
50. Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance. van der Meulen KM; Favoreel HW; Pensaert MB; Nauwynck HJ Vet Immunol Immunopathol; 2006 May; 111(1-2):31-40. PubMed ID: 16472872 [TBL] [Abstract][Full Text] [Related]
51. Immunologic relationships between equine herpesvirus type 1 (equine abortion virus) and type 4 (equine rhinopneumonitis virus). Fitzpatrick DR; Studdert MJ Am J Vet Res; 1984 Oct; 45(10):1947-52. PubMed ID: 6208822 [TBL] [Abstract][Full Text] [Related]
52. Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets. Breathnach CC; Soboll G; Suresh M; Lunn DP Vet Immunol Immunopathol; 2005 Feb; 103(3-4):207-15. PubMed ID: 15621307 [TBL] [Abstract][Full Text] [Related]
53. In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1-infected target cells. Wilks CR Am J Vet Res; 1977 Jan; 38(1):117-21. PubMed ID: 189645 [TBL] [Abstract][Full Text] [Related]
54. The role of secreted glycoprotein G of equine herpesvirus type 1 and type 4 (EHV-1 and EHV-4) in immune modulation and virulence. Thormann N; Van de Walle GR; Azab W; Osterrieder N Virus Res; 2012 Oct; 169(1):203-11. PubMed ID: 22902480 [TBL] [Abstract][Full Text] [Related]
55. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection. Paillot R; Ellis SA; Daly JM; Audonnet JC; Minke JM; Davis-Poynter N; Hannant D; Kydd JH Vaccine; 2006 Mar; 24(10):1490-500. PubMed ID: 16269205 [TBL] [Abstract][Full Text] [Related]
56. Antibody and cellular immune responses of naïve mares to repeated vaccination with an inactivated equine herpesvirus vaccine. Wagner B; Goodman LB; Babasyan S; Freer H; Torsteinsdóttir S; Svansson V; Björnsdóttir S; Perkins GA Vaccine; 2015 Oct; 33(42):5588-5597. PubMed ID: 26384446 [TBL] [Abstract][Full Text] [Related]
57. Evaluation of metaphylactic RNA interference to prevent equine herpesvirus type 1 infection in experimental herpesvirus myeloencephalopathy in horses. Perkins GA; Van de Walle GR; Pusterla N; Erb HN; Osterrieder N Am J Vet Res; 2013 Feb; 74(2):248-56. PubMed ID: 23363350 [TBL] [Abstract][Full Text] [Related]
58. Function of myosin during entry and egress of equid herpesvirus type 1 in primary murine neurons. Cymerys J; Słońska A; Skwarska J; Bańbura MW Acta Virol; 2016; 60(4):410-416. PubMed ID: 27928922 [TBL] [Abstract][Full Text] [Related]
59. Equine herpesvirus 1 elicits a strong pro-inflammatory response in the brain of mice. Mesquita LP; Costa RC; Zanatto DA; Bruhn FRP; Mesquita LLR; Lara MCCSH; Villalobos EMC; Massoco CO; Mori CMC; Mori E; Maiorka PC J Gen Virol; 2021 Mar; 102(3):. PubMed ID: 33528354 [TBL] [Abstract][Full Text] [Related]
60. The effect of equine herpesvirus type 4 on type-I interferon signaling molecules. Oladunni FS; Reedy S; Balasuriya UBR; Horohov DW; Chambers TM Vet Immunol Immunopathol; 2020 Jan; 219():109971. PubMed ID: 31739157 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]